04/27/2021
Health Canada is updating labelling for the AstraZeneca and COVISHIELD vaccines with warnings about the potential side effects of rare events of blood clots, and to provide information about the signs and symptoms.
The department said it has reviewed available data from Europe and the United Kingdom and has not identified any specific risk factors for developing blood clots. It said the overall risk of these blood clots is approximately 4 people per one million, and the benefits of the vaccine in protecting against COVID-19 outweigh its potential risks.
There was one case of blood clots reported this past week in Canada.
For patients who have received the AstraZeneca or COVISHIELD vaccine, if the following symptoms develop four days or more after vaccination, they should seek medical attention:
*Shortness of breath
*Chest pain
*Leg swelling
*Persistent abdominal (belly) pain
neurological symptoms, such as severe and persistent worsening headaches or blurred visionskin bruising or tiny blood spots under the skin beyond the site of the injection.
Please call us at 604-705-1030 if you have any inquiries regarding Covid-19.
We wish everyone well.